XML 93 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Share Capital (Details) - USD ($)
 1 Months Ended 12 Months Ended
Nov. 28, 2022
Oct. 08, 2020
Dec. 31, 2022
Nov. 28, 2022
Aug. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Feb. 17, 2022
Jul. 23, 2021
Share Capital (Details) [Line Items]                    
Agreement description   Smart Pro entered into a definitive agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro, acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro’s’ previous shareholders in consideration for restricted American Depository Shares (“ADS”) of Medigus and a cash component. Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company, with the value of restricted ADS to be subject to downward adjustment based on Smart Pro’s 2020 results. In addition, Smart Pro’s current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject to Smart Pro ’s achievement of certain milestones throughout 2021.                
Issued and outstanding share capital percentage   50.01%                
Invest amount   $ 150,000                
Additional payroll expenses             $ 60,000      
Exercise price (in Dollars per share)         $ 2.02          
Warrants issuance costs           $ 8,220,000        
Issuance of bonus shares (in Shares)                 664.0547  
Aggregate issuance shares (in Shares)                 6,630,547  
Gross proceeds         $ 58,000          
Warrants purchase shares (in Shares)         185,873          
Price per share (in Dollars per share)     $ 6.06   $ 4.04 $ 6.06        
Initial exercise price expire         5 years          
Exercise price less (in Dollars per share)         $ 2.02          
Exercise price (in Dollars per share) $ 2.02                  
Additional warrant term 5 years                  
Revenues percentage 2.30%   2.30%              
Fair value warrants           $ (2,822,000) $ 75,000    
Additional warrants description On November 28, 2022, following the issuance of the Additional warrants, the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser valuation, was recorded as a component of Group’s shareholder’s equity. (Refer also to Note 9c). The total gross consideration was 15.5 million (including the exercise of the underwriter’s option at the amount of $4 thousands). $8,245 thousand was initially attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been recorded in equity as a reduction of the paid in capital.                   
Warrants issuance costs         $ 1,000          
Total consideration         4,000          
Common Stock, Shares, Issued (in Shares)     8,074,217     8,074,217 2,893,125      
Ordinary Shares [Member]                    
Share Capital (Details) [Line Items]                    
Shares issued (in Shares)   557                
Warrants issuance costs         51,000          
Considered as issuance costs         $ 500          
Common Stock, Shares, Issued (in Shares)         1,463,619          
Maximum [Member]                    
Share Capital (Details) [Line Items]                    
Fair value warrants           $ 4,651,000        
Minimum [Member]                    
Share Capital (Details) [Line Items]                    
Fair value warrants           $ 3,594,000        
Ordinary Shares [Member]                    
Share Capital (Details) [Line Items]                    
Shares issued (in Shares)         3,717,473          
IPO [Member]                    
Share Capital (Details) [Line Items]                    
Divided ordinary shares amount             $ 75,000      
Issuance of period term             2 years      
Ordinary shares exercisable (in Shares)         18,564          
Ordinary shares exercisable term         5 years          
Ordinary shares exercisable per share (in Dollars per share)         $ 4.04          
Exercise price (in Dollars per share) $ 2.02     $ 2.02 $ 5.2          
Warrants issuance costs             $ 12,000      
Warrants purchase shares (in Shares)         3,717,473          
Price per share (in Dollars per share)         $ 4.16          
Fair value warrants       $ 3,319,000            
Warrants issuance costs         $ 109,000          
Considered as issuance costs         500          
Over-Allotment Option [Member]                    
Share Capital (Details) [Line Items]                    
Gross proceeds         $ 15,500,000          
Warrants purchase shares (in Shares)         425,912          
Ordinary Shares [Member]                    
Share Capital (Details) [Line Items]                    
Warrants purchase shares (in Shares) 2,824,525     2,824,525            
Majority Shareholder [Member]                    
Share Capital (Details) [Line Items]                    
Shares issued (in Shares)                   33,202
Minority shareholder amount             $ 60,000